It's also accredited for adults who will be overweight with a number of pounds-similar ailments, for example high blood pressure or Style 2 diabetic issues (superior blood sugar). In March of 2024, the FDA authorized a further indicator for Wegovy—to lessen the potential risk of cardiovascular death, heart attack, and https://glp-1weightlossmed.com/product/wegovy/